Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology SuccessBy mariocazombo76@gmail.com / February 21, 2025
Bristol-Myers Squibb: Too Valuable Not To Hold This Pharma Gem, But Debt Challenges Remain January 31, 2025 / Albert Anthony, BMY / By mariocazombo76@gmail.com
Busy Earnings Season Continues With Alphabet, Disney, Palantir To Report Results February 1, 2025 / ACCD, AMD, AMGN, ARM, BBD, BMY, CBOE, CLX, COP, DIS, EA, FCEL, FTV, GOOG, GOOGL, GRO, HON, ICAD, IDXX, KIM, LIN, LLY, MARK, MSTR, NBIX, NVDA, NVO, NXPI, PEP, PLTR, PMNT, QCOM, RCT, REKR, SDST, TOI, TSN, TTAM, UBER, Wall Street Week Ahead / By mariocazombo76@gmail.com
By
/ February 21, 2025 By
/ February 21, 2025 By
/ February 21, 2025 By
/ February 21, 2025 By
/ February 21, 2025 By
/ February 21, 2025